Podcasts about transplants

In this powerful and moving conversation, we sit down with the ever-so-joyful Simply Sayo to discuss her personal experience living with sickle cell and how she has used her sister's story to raise awareness and spread joy. We talk about the realities of navigating chronic illness, the power of storytelling, and what true advocacy looks like within the Black community. This episode is a reminder of how strength, softness, and sisterhood can coexist—even in the face of pain.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Sernova has a new partner and a new drug for cell transplants, at home glucose/T1D test research, study looks at best diet for people with type 2, Lifescan files for banktrupcy, T1D Barbie and more! Find out more about Moms' Night Out  Read Hangy Woman's take on Barbie (and send me yours!)  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: In the News July 18   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Sernova is partnering with Eledon Pharmaceuticals to test a new immunosuppressive drug in its ongoing clinical trial for people with type 1 diabetes (T1D). The drug called tegoprubart is designed to protect transplanted islet cells without harsh side effects. The current treatment is known for its potential toxicity, especially towards insulin-producing beta cells, and its adverse side effects, making it less than ideal for islet cell therapy in T1D. Tegoprubart has already shown promise in earlier trials, helping T1D patients achieve insulin independence with better graft survival and fewer side effects. This next phase of Sernova's trial (Cohort C) will combine Eledon's drug with Sernova's Cell Pouch, an implantable device that houses insulin-producing cells. In earlier phases, six participants stopped needing insulin completely, with results lasting years. Sernova also plans to use stem cell-derived islet-like clusters from partner Evotec to create a next-gen therapy. If all goes well, a new clinical program could launch in 2026.   https://www.streetwisereports.com/article/2025/07/15/biotech-partnership-to-revolutionize-diabetes-treatment.html XX Researchers at Yale School of Medicine, funded by Breakthrough T1D, are evaluating GTT@home, a new finger-prick, at-home glucose tolerance test, to monitor early-stage type 1 diabetes (T1D) in individuals with T1D autoantibodies. Developed by Digostics (Dih-jos-tiks), the test offers a simpler, less invasive alternative to clinic-based oral glucose tolerance tests. The study aims to assess its accuracy, usability, and acceptance, potentially paving the way for wider use in early T1D detection and monitoring. The results of the trial will inform future regulatory submissions for GTT@home use in T1D, which already has regulatory approval in the UK, Europe and other regions for other types of diabetes. https://finance.yahoo.com/news/digostics-announces-university-trial-home-164300142.html XX LifeScan announced that it entered into a restructuring support agreement and, to implement it, filed for chapter 11 bankruptcy. As the process moves forward, LifeScan plans to operate in the ordinary course of business. It expects to emerge from chapter 11 by the end of the year. LifeScan develops the OneTouch Bluetooth-connected blood glucose meter and mobile diabetes app that provide simplicity, accuracy and trust in diabetes management. XX New study looks at quality of life and cost of AID systems. This was done in Finland which has the highest prevalence of T1D in the world. The results show automated insulin delivery pumps significantly improved quality of life and reduced diabetes-related complications. The quality-adjusted life expectancy increased by an average of 2.3 years for individuals using an automated insulin delivery pump. Although the overall costs of automated insulin delivery pump treatment were higher than those of conventional insulin pump treatment, its cost-effectiveness ratio was well below the generally accepted willingness-to-pay threshold of 50,000 euros in Finland. This is the first cost-effectiveness study of automated insulin delivery pumps conducted in Finland. https://medicalxpress.com/news/2025-07-automated-insulin-delivery-effective-treatment.html XX Blue Circle Health expands into the 11th state: Louisiana! This is Free, comprehensive virtual clinical care, education, and support program for adults with type 1 diabetes In addition to serving adults with type 1 diabetes in Louisiana, our program is also active in Alabama, Mississippi, Florida, Missouri, Iowa, Ohio, Vermont, New Hampshire, Maine, and Delaware.  The program serves as an extension of participants' existing care teams and ensures continuity of care The organization hopes to inform new care models and policies that remove barriers to healthcare People with T1D over 18 years of age who speak English or Spanish are eligible to enroll. To sign up directly, refer a person living with T1D, or learn how you can partner with Blue Circle Health, visit www.bluecirclehealth.org. XX A new study comparing three popular diets—intermittent fasting, time-restricted eating, and continuous calorie cutting—found that all can help people with type 2 diabetes lose weight and lower blood sugar. But one diet stood out: the 5:2 intermittent fasting plan, where participants eat normally five days a week and restrict calories on two. It led to better results in fasting blood sugar, insulin response, and sticking with the plan. Although researchers identified improved HbA1c levels, and adverse events were similar across the three groups, the IER group showed greater advantages in reducing fasting blood glucose, improving insulin sensitivity, lowering triglycerides, and strengthening adherence to the dietary interventions. https://www.sciencedaily.com/releases/2025/07/250715043351.htm XX MIT students have developed an implantable device.. for use during emergency low blood sugars.   The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.   The researchers showed that this device could also be used to deliver emergency doses of epinephrine, a drug that is used to treat heart attacks and can also prevent severe allergic reactions, including anaphylactic shock. The device contains a powdered form of glucagon and can be remotely triggered—either manually or automatically by a glucose monitor—to release the hormone when blood sugar drops too low. No word on next steps to make this commercially available.   https://news.mit.edu/2025/implantable-device-could-save-diabetes-patients-low-blood-sugar-0709 XX We've covered T1D1 before, this is an insulin calculator app – there's more to it than that.. it was created by 13 year old Drew who lives with type 1, but removed from the apps stores a few years ago, along with other non fda cleared apps. Drew who is now 18, Tells us they just submitted to the FDA and are optimistic about being reinstated. https://www.instagram.com/t1d1app/ XX   XX 1'm Brodie Sargent, a Type 1 diabetic raised in Mudgee, NSW, and currently living in Wollongong.   Starting August 26th, I'll be running a marathon every day for 26 days, and on the 27th day, I'll be finishing with Western Sydney's Half Ironman.   The current world record for the most consecutive marathons run by a Type 1 diabetic male is 25 and I'm aiming to break it.   I'm doing this to inspire others, diabetic or not, to challenge themselves and not let anything hold them back.   Any donation is greatly appreciated and supports a cause I truly believe in. The Type One Foundation focuses on support, connection, awareness, and advocacy for diabetics across Australia. They run online and in-person events for diabetics and their families, and also offer care packages to those newly diagnosed.   I was diagnosed at 15, and it was a tough time for me and my family, we had no history or understanding of diabetes. I was already a shy and awkward kid, and I struggled to speak up about how much it affected me. I started running with my roommate just to kill time but it quickly took over my life. Feeling stuck and unsure where I was heading, I decided to make a change and try to help anyone out there feeling the same way.   You can follow my journey on Instagram: @typerun_   XX Launched during children's congress To further promote inclusivity and tackle the stigma associated with the condition, Mattel partnered with Breakthrough T1D, a global organization dedicated to type 1 diabetes research and advocacy, to launch its first Barbie with type 1 diabetes. This partnership marks a major milestone in Mattel's commitment to greater representation, and highlights Breakthrough T1D's pivotal role in ensuring visibility for the type 1 diabetes community.   The doll is part of the Barbie Fashionistas line and includes key diabetes management tools modeled accurately with the help of Breakthrough T1D. The type 1 diabetes Barbie wears a continuous glucose monitor (CGM) secured with Barbie-pink, heart-shaped tape, and has an insulin pump at her waist. She also comes with a CGM-tracking smartphone, a pastel blue purse, and a blue polka dot outfit – blue being the color that symbolizes global diabetes awareness.   As part of a broader initiative to elevate voices in the type 1 diabetes community, Barbie also partnered with two global role models living with type 1 diabetes: Peloton Instructor Robin Arzón and model Lila Moss.   Robin Arzon Barbie Image Credit: Breakthrough T1D and Mattel Mattel's one-of-a-kind doll based on Arzón features her signature yellow outfit and a crown-shaped CGM on the back of her arm.   In interviews, Moss has highlighted the positive impact that the type 1 diabetes Barbie's visibility has already had, saying she receives daily messages from young people who feel less insecure about wearing their diabetes devices thanks to her public advocacy.   When Linxi Mytkolli, director of patient engagement at Diabetes Action Canada and person with diabetes, heard about the new “Dia Barbie,” she said she teared up.   “I grew up loving dolls, but I never saw one that reflected the reality I now live with – until Dia Barbie. Seeing a doll with a CGM, insulin pump, and even heart-shaped medical tape felt surreal. It's playful, powerful, and personal all at once,” said Mytkolli.   Mytkolli also emphasized that representation and visibility in toys and media can help chip away at shame.   “I've heard from so many people, especially those diagnosed in childhood, who delayed using tech like pumps or CGM because it felt like a punishment. Visibility in toys helps normalize these devices and makes kids feel like they're not alone or ‘othered.' It turns stigma into something softer – something that can be talked about, shared, even celebrated,” Mytkolli said.   And its impact goes beyond people living with diabetes. Laura Pavlakovich, who is the founder and CEO of You're Just My Type and has lived with type 1 diabetes since age five, shared that this representation is equally crucial for those without diabetes, as it demystifies the condition and challenges stereotypes.   “This kind of representation builds a vital bridge of empathy, illustrating that living with diabetes is simply a part of life for millions. It's an essential tool for educating the public and cultivating a more inclusive and supportive society for everyone,” said Pavlakovich.   Pavlakovich shared her personal experience of growing up with diabetes and how this will provide validation for those with the condition who often feel unseen.   “I vividly remember growing up with a 'my twin' doll, custom-made to look just like me, yet she always lacked the crucial part of my daily reality: an insulin pump. To finally see a Barbie, an iconic figure in childhood play, accurately depict someone living with type 1 diabetes, complete with her devices and pump, is truly a monumental moment,” said Pavlakovich.   To celebrate the launch, Barbie donated dolls to the Breakthrough T1D 2025 Children's Congress in Washington, D.C., where 170 young advocates for type 1 diabetes from around the world met with lawmakers to raise awareness. Priced at $10.99, the doll is now available on Mattel Shop and at retailers nationwide.   While this is a huge win for enhancing the representation of children living with diabetes, it doesn't end there. There is still significant work to be done to improve access to diabetes medication and technology.   “It is not lost on me that Barbie has more access to diabetes tech than many, if not most, people with diabetes globally,” said Mytkolli. “Representation and access – we deserve both.”   By bringing a common but misunderstood condition into children's toy boxes, the new type 1 diabetes Barbie is more than a toy. It's a symbol of pride, visibility, and the message that children with diabetes can live full, empowered lives.   As Mytkolli said, “Whether a child is living with diabetes, or loves someone who is, this doll quietly says, ‘You're not broken. You belong.'”

What happens when a teenager on the brink of death chooses to turn his pain into purpose? You get Transplant Teenz—a growing community founded by 14-year-old heart transplant recipient, Micah Clayborne. https://www.klove.com/news/god-stories/from-transplant-to-testimony-how-one-teen-s-miracle-is-creating-a-movement-andpodcast-55696

In this episode of the Gladden Longevity Podcast, Dr. Jeffrey Gladden interviews Dr. Alan Bauman, a leading expert in hair restoration. They discuss Dr. Bauman's journey into the field, the evolution of hair transplantation techniques, and the importance of scalp health and nutrition in hair restoration. Dr. Bauman shares insights on the advancements in Follicular Unit Extraction (FUE), the future of hair cloning, and the role of personalized regenerative treatments. The conversation emphasizes the significance of taking action against hair loss and the exciting developments in regenerative medicine.   For Audience ·       Use code 'Podcast10' to get 10% OFF on any of our supplements at https://gladdenlongevityshop.com/ !    Takeaways ·       Dr. Bauman's journey into hair transplantation began unexpectedly. ·       The evolution of hair restoration techniques has significantly improved outcomes. ·       Follicular Unit Extraction (FUE) is a less invasive method for hair transplants. ·       Scalp health is crucial for successful hair restoration. ·       Nutritional status impacts hair growth and restoration. ·       Innovative treatments like exosomes are enhancing hair restoration results. ·       The future of hair cloning holds promise for unlimited hair supply. ·       Personalized regenerative treatments are becoming more accessible. ·       Legal changes are opening doors for regenerative medicine. ·       Patient engagement is key to successful hair restoration journeys.   Chapters 00:00 Introduction to Hair Restoration and Dr. Bauman's Journey 02:54 Evolution of Hair Transplant Techniques 05:38 The Shift to Follicular Unit Extraction (FUE) 08:27 Innovations in Hair Transplant Technology 11:18 Understanding Hair Follicle Health and Growth 14:22 Holistic Approaches to Hair Restoration 17:03 Nutritional Factors in Hair Health 18:27 Holistic Approaches to Hair Restoration 19:36 Scalp Health and Its Impact on Hair Growth 21:01 Optimizing Recovery with Nutrition and Therapies 22:22 Innovative Treatments for Scarring and Healing 23:39 Transformational Stories in Hair Restoration 24:46 The Concept of Living Young for a Lifetime 25:50 Advancements in Hair Cloning Technology 28:32 Personalized Regenerative Medicine in Hair Treatments 30:35 Combining Treatments for Enhanced Results 32:40 Regulatory Changes in Regenerative Medicine 36:06 Access to Innovative Treatments and Clinical Trials   To learn more about Dr. Alan Bauman: Email: alanjbauman@me.com Website: https://www.baumanmedical.com/ Facebook: https://www.facebook.com/alanjbauman LinkedIn: https://www.linkedin.com/in/alanjbauman/ Instagram:  https://www.instagram.com/DrAlanBauman/   Reach out to us at:    Website: https://gladdenlongevity.com/     Facebook: https://www.facebook.com/Gladdenlongevity/    Instagram: https://www.instagram.com/gladdenlongevity/?hl=en     LinkedIn: https://www.linkedin.com/company/gladdenlongevity    YouTube: https://www.youtube.com/channel/UC5_q8nexY4K5ilgFnKm7naw 

Did you know that people who have received a kidney transplant are at a much higher risk for skin cancer? We sat down with experts to discuss how you can lower your risk. In this episode we heard from: Dr. Cerrene Giordano is a dermatologist and Mohs Micrographic surgeon at Roswell Park Comprehensive Cancer Center in Buffalo, New York. She specializes in treating skin cancers, particularly in patients who are high risk such as those who have received organ transplants, have weakened immune systems, or a genetic predisposition to skin cancer development. Her expertise includes skin cancer surgery, wound reconstruction, and the management of skin cancers such as melanoma, basal cell carcinoma, and squamous cell carcinoma, to name a few. Dr. Giordano is also involved in research aimed at improving pain management following dermatologic surgeries and exploring advanced imaging techniques to enhance surgical outcomes. Kent Bressler is a retired RN who was diagnosed with FSGS in 1984, and received a living donor transplant from his brother Kip in 1987. Kent is an active advocate for preemptive kidney transplant and has on the recommendation of NKF worked closely with the DoD and PCORI as a consumer peer reviewer. He is an NKF peer mentor and advocate who has collaborated on an editorial “Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of Chronic Kidney Disease,” published in AJKD in 2019. He will also be participating in the development of the new NKF Patient Network serving on the Data Input and Integration Committee. He has been an active hill advocate for the NKF for six years and was the proud recipient of the 2017 Richard K. Salick Advocacy Award. Kent is also an Army Veteran and retired from the Veterans administration as an RN. He is the co-founder of Kidney Solutions a not for profit program in Texas that assists patients and families in the transplant process and in finding a donor. He is currently an assistant team leader for Region 7. Kent and Cathy Bressler have been married for 56 years and their family consists of Gretchen and Todd Rossington and their son Colt and Celeste and Alex Brown and their children John Banks, Catherine and Alexis Brown. Risa Simon is a passionate author, speaker, mentor, kidney patient coach and advocate. As the founder and CEO of The Proactive Path and the TransplantFirst Academy, her mission is to help all kidney disease patients advocate for their best life possible—the life she now lives. As a preemptive kidney transplant recipient, Risa was able to circumvent the need for dialysis. This is her hope for all eligible kidney patients. Risa gives back a good portion of her time by serving on various advisory committees, such as the National Kidney Foundation's (NKF's) Kidney Action committee, the American Association of Kidney Patients (AAKP) program and convention committees and she chairs the Phoenix Chapter's Polycystic Kidney Disease (PKD) education committee.  She is also a member of the PKD Legacy Society and serves as a Peer Mentor for the National Kidney Foundation (NKF). Risa's message is all about empowering kidney patients to bring their voice to life.    Additional Resources: Dr. Cerrene Giordano Protect the Skin You're In Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

On the struggle bus—

In this episode, we share why Matt's changed his mind about baby number three. We also talk about the Shettles Method, a theory on how to increase your chances of having a girl. Matt opens up about his upcoming hair transplant, we celebrate our sixth wedding anniversary and give some fun life updates. This episode is sponsored by Magic Spoon, Cash App & Hiya: Magic Spoon: Go to ⁠https://magicspoon.com/UNPLANNED⁠ and receive $5 off. Cash App: Download Cash App Today: https://capl.onelink.me/vFut/kssum24w #CashAppPod Hiya: Go to ⁠https://hiyahealth.com/UNPLANNED⁠ and receive 50% off your first order. Get your kids the full-body nourishment they need to grow into healthy adults. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Your Health First: Advancements in Robotic Surgery & Live Liver Donation at Houston MethodistJoin Dr. Joe Galati on this episode of "Your Health First" as he speaks with leading surgeons from Houston Methodist Hospital, Dr. Simon and Dr. Yee Lee Cheah. Broadcasting live from 740 KTRH in Houston and worldwide on the iHeartRadio app every Sunday at 7:00 PM Central, this insightful discussion delves into the groundbreaking work being done in robotic surgery and the current status of the live donor liver transplant program at Houston Methodist.Dr. Simon and Dr. Cheah share their expertise on the numerous benefits of robotic surgery, highlighting the significant advantages for patients and the remarkable advancements in technology over the past 5-10 years. They also provide a comprehensive overview of the meticulous patient selection process for live liver donors and detail the structured program at Houston Methodist Hospital.Don't miss this opportunity to learn about the cutting-edge surgical techniques and life-saving transplant procedures making a difference in patient care.For more information:Dr. Simon & Dr. Cheah: www.houstonmethodist.orgDr. Joe Galati: www.drjoegalati.comGuest Biographies:Dr. Simon:Dr. Simon is a highly accomplished surgeon with a specialization in abdominal transplantation and hepatobiliary surgery. She earned her medical degree with honors from University College Cork Faculty of Medicine in Ireland in 2002 and completed her general surgery residency at Brown University Program, Rhode Island Hospital. Dr. Simon further honed her expertise with a research fellowship in Diagnostic Imaging at Brown University and an ASTS-certified fellowship in Abdominal Transplantation and Hepatobiliary Surgery at Lahey Hospital & Medical Center. Her clinical interests are extensive, encompassing both benign and malignant tumors of the liver, bile duct, and pancreas, including hepatocellular carcinoma and Klatskin tumors. She is also deeply involved in kidney transplantation, living and deceased donor liver transplantation, pancreatic carcinoma, robotic surgery, and surgery for portal hypertension. Dr. Simon is board-certified in general surgery by the American Board of Surgery and is a Fellow of the American College of Surgeons (FACS).Dr. Yee Lee Cheah:Dr. Yee Lee Cheah is a distinguished surgeon who joined the J.C. Walter Jr. Transplant Center at Houston Methodist Hospital in 2022. She graduated with honors from the Royal College of Surgeons in Ireland in 2000 and completed her General Surgery Residency at the Brown University Program. Dr. Cheah further specialized with an ASTS-accredited fellowship in Transplantation & Hepatobiliary Surgery at the Lahey Clinic. Prior to Houston Methodist, she played a pivotal role at the Asian American Liver Centre at Gleneagles Hospital, the largest adult living donor liver transplantation (LDLT) center in Southeast Asia, before returning to LHMC to develop their LDLT and robotic surgery programs. Her expertise lies in living donor liver transplantation, robotic transplantation, HPB surgery for benign and malignant disorders, and nutrition therapy for surgical patients. Dr. Cheah's main research interests are centered on living donor safety and robotic surgery. She has held faculty positions at Brown University and Tufts University and served as an Adjunct Assistant Professor at the National University of Singapore. Hosted on Acast. See acast.com/privacy for more information.

How can interventional radiologists turn their unique capabilities into revenue? Dr. Matt Hawkins, interventional radiologist and Health Policy and Economics councilor at the Society of Interventional Radiology (SIR), joins host Dr. Ally Baheti to discuss how interventional radiologists can prove (and get paid for) the value that they bring to hospitals. --- This podcast is supported by: Medtronic Emprinthttps://www.medtronic.com/emprint RADPAD® Radiation Protectionhttps://www.radpad.com/ --- SYNPOSIS The doctors discuss key physician reimbursement models, including the Hospital Outpatient Prospective Payment System (HOPPS) for hospital outpatient and Diagnosis-Related Groups (DRGs) for hospital inpatient, as well as strategies for negotiating subsidies. Dr. Hawkins covers key strategies for proving the value of IR to hospitals, emphasizing the importance of moving beyond work RVUs and focusing on the technical revenue generated for hospitals. The discussion underscores the critical role that IR plays in trauma, transplant, and cancer care. Lastly, Dr. Hawkins highlights SIR's economic initiative emphasizing the importance of accurate documentation and coding in order to turn our clinical impact into measurable value. --- TIMESTAMPS 00:00 - Introduction01:58 - Understanding Professional and Technical Reimbursement04:49 - Hospital Reimbursement Structures07:59 - Quantifying Value and Negotiating Contracts15:55 - Economic Arguments for IR in Trauma, Transplant, and Cancer23:01 - The Importance of IR Leadership in Mixed IRDR Groups25:13 - Challenges and Strategies for Independent IR Practices28:41 - Maximizing Revenue Through Evaluation and Management (E&M)36:40 - Navigating Coding and Documentation for Better Negotiation38:54 - Financial Literacy and Business Strategies

In 2019, British-Nigerian comedian Emmanuel Sonubi suffered from a near-fatal heart failure whilst on a comedy tour of Dubai. He had a condition called dilated cardiomyopathy, which means his heart was not pumping enough oxygen around his body, and he might need an urgent transplant. In the years since Emmanuel's condition has been controlled through medication but the threat of a heart transplant still looms large – as does the shortage of donors from people of his background where he lives in the UK. Emmanuel examines the cultural attitudes which stop people from taking part in organ donation and transplantation. He also hears from Dr. Beatriz Domínguez-Gil, director general of Organización Nacional de Trasplantes and Lalitha Raghuram, one of the leaders of the MOHAN Foundation, which helps spread awareness of organ donation across India.

Diagnosed with Type 1 diabetes at 11 and later with end-stage renal disease, Suzanne drew on her personal experience to write an MSc thesis exploring the lived challenges of adhering to a highly restrictive dialysis diet. Following her kidney transplant, she was struck by the lack of clear nutrition guidance for transplant recipients, making the transition to managing her new kidney particularly difficult. Determined to fill this gap, she conducted research to develop evidence-based dietary guidelines, which she published in Transplant International and presented at the European Keto Live Conference in Switzerland. X: https://x.com/suzeschneider Instagram: https://www.instagram.com/zanne_schneider/ Timestamps: 00:00 Trailer 00:47 Introduction 05:50 Balancing diet after transplant 07:55 Exploring post-transplant protein needs 14:23 Protein benefits for diabetics 18:35 Optimizing immunosuppressants with diet 21:22 White blood cells and inflammation 26:43 "Life transformation after organ transplant" 30:12 Transplant eGFR limitations 34:04 Challenges of cooking vs. convenience 35:46 Practicing outside NHS 39:37 Managing type 1 with sports 43:53 Double transplant 45:45 Pancreatic transplantation challenges 49:57 Where to find Suzanne Join Revero now to regain your health: https://revero.com/YT Revero.com is an online medical clinic for treating chronic diseases with this root-cause approach of nutrition therapy. You can get access to medical providers, personalized nutrition therapy, biomarker tracking, lab testing, ongoing clinical care, and daily coaching. You will also learn everything you need with educational videos, hundreds of recipes, and articles to make this easy for you. Join the Revero team (medical providers, etc): https://revero.com/jobs ‪#Revero #ReveroHealth #shawnbaker  #Carnivorediet #MeatHeals #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree Disclaimer: The content on this channel is not medical advice. Please consult your healthcare provider.

"I've been given life to affect life, and that's what I'm grateful for." - Mark Durante Mark Durante is the inspiring founder of Rize Up Medical, known for his pioneering work in regenerative medicine. After enduring a life-changing heart transplant and overcoming severe neuropathy pain through regenerative therapies, Mark dedicated himself to transforming patient care. His company, Rize Up Medical, empowers medical practitioners nationwide by incorporating cutting-edge regenerative therapies into their practices, revolutionizing patient outcomes and improving healthcare methodologies. Mark's compelling journey from a heart transplant patient to a leader in medical innovation highlights his commitment to improving lives through advanced medical practices. Episode Summary: In this captivating episode of "All My Health, There's Hope," host Jana Short engages with Mark Durante, founder of Rize Up Medical, in a heartfelt conversation about the power of regenerative medicine and his incredible personal journey. Mark shares his transformative experience from being a patient in need of a heart transplant to becoming a groundbreaking figure in regenerative therapies. His story is a testament to overcoming adversity and harnessing the potential of innovative medical treatments to improve the lives of patients nationwide. Mark Durante delves into the specifics of his journey with neuropathy and heart failure, shedding light on how regenerative medicine played a pivotal role in his recovery and eventual mission to help others. Through the Rize method, Mark has helped numerous practitioners implement regenerative solutions, addressing a range of conditions, from cardiac and neurological issues to orthopedic concerns. With a focus on wellness and sustainable health solutions, Mark's insights provide valuable knowledge on how the intersection of technology, medicine, and patient care can lead to life-changing outcomes. Notably, this episode underscores the importance of organ donation and how medical advancements can offer renewed hope for those facing debilitating health challenges. Key Takeaways: Mark Durante's transformative experience with a heart transplant and neuropathy led him to pioneer regenerative medicine advancements. Rize Up Medical aids practitioners in integrating cutting-edge regenerative therapies, enhancing patient care and practice growth. Regenerative medicine offers hope for numerous conditions, from neurological to orthopedic, showing promise in rejuvenating health. Advances in biologics and regenerative methods can positively impact aesthetics, wellness, and longevity, providing pathways to a better quality of life. The episode highlights the critical role of organ donation and how innovative medical treatments are pivotal in saving lives and offering hope. Resources www.rizeupmedical.com IG: @‌rizeupmedical FB: @‌rizeupmedical https://www.linkedin.com/in/mark-durante/ Get in touch with Jana and listen to more Podcasts: https://www.janashort.com/ Show Music ‘Hold On' by Amy Gerhartz https://www.amygerhartz.com/music. Get the Best Holistic Life Magazine Subscription! It is one of the fastest-growing independent magazines centered around holistic living. https://bestholisticlife.info/BestHolisticLifeMagazine Grab your gift today: https://bestholisticlife.info/BestHolisticLifeMagazine Connect with Jana Short: https://www.janashort.com/contact/

What happens when your soul begins to leave your body? Terry Wright knows that feeling intimately. Terry founded Lifeline Pregnancy Center, combining her nursing background with her passion for supporting women in crisis pregnancies. The center provides education, material support, and shares the gospel with every client. While standing at a copy machine at Lifeline, she suddenly collapsed and was taken to the Emergency Room.  While there, a shocking discovery was made. Her heart was failing. But why?In this powerful conversation, Terry shares her extraordinary journey from sudden collapse to heart failure that left doctors puzzled. With no prior cardiovascular issues, she found herself declining rapidly until she was hospitalized, waiting for a donor heart while actively dying.Terry takes us to the edge of mortality itself, describing with remarkable clarity how she felt her soul slowly separating from her weakening body. The medical staff's hushed tones told her family "this is what happens at the end of the end." As she prepared to meet Jesus, Terry's overwhelming regret wasn't about missed vacations or career achievements – it was that she hadn't done more for God's Kingdom.Then came the miracle. A late-night call announced a perfectly matched heart was available. The emotional whiplash of moving from death's doorstep to a second chance at life led Terry to profound spiritual insights about God's authority and timing. Her meeting with the donor family – who lost their 18-year-old daughter but honored her wish to donate organs – reveals the beautiful redemption possible even in tragedy.Her powerful testimony illustrates how God's promises become real when we fully surrender to His purposes.Whether you're facing life-altering challenges or simply questioning your purpose, Terry's journey will inspire you to consider how you're using your own "window of opportunity." What race has God set before you? The clock is ticking for all of us – what will you do with the time you've been given?Support the showThank you for listening!! Please give us a five-star rating to help your podcast provider's algorithm spread RTTB among their listeners. You can find free study and leader resources at the following link - Resource Page - Reasoning Through the Bible Please prayerfully consider supporting RTTB to help us to continue providing content and free resources. You can do that at this link - Support RTTB - Reasoning Through the Bible May God Bless you!! - Glenn and Steve

Dr. Chris Khorsandi (IG: docvegas) is a renowned plastic surgeon and founder of VIP Plastic Surgery in Las Vegas. He blends aesthetics with psychology, aiming to align inner identity with outer appearance. ————————————————————

Declan Buckley, Amanda Brunker and Seán Moncrieff help tackle listener dilemmas!

This week, we dig into the surprising shift among voters who once supported private equity in healthcare—and may now be rethinking it. Kristin and I talk through what's behind that change, plus a major headline about the first-ever eye transplant. And just when things start to feel a little too serious, we lighten it up with a chaotic game that puts our anatomy knowledge (and humility) to the test. Trust me, you'll want to play along. Takeaways: Some voters are finally reconsidering their stance on private equity's role in healthcare—what changed? A groundbreaking eye transplant sparks conversation about what's medically possible… and what still isn't. The line between actual anatomy and total nonsense is thinner than you think—especially when you're being timed. Kristin has strong thoughts about “buzzword healthcare policy.” We all need a reminder that it's okay to laugh at ourselves—even when we're supposed to know this stuff. — To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: https://glaucomflecken.com/glauc-to-me/ If you are interested in buying a book from one of our guests, check them all out here: https://www.amazon.com/shop/dr.glaucomflecken If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: https://anatomywarehouse.com/?aff=14 Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content Learn more about your ad choices. Visit megaphone.fm/adchoices

Send Sherry a Text MessageEver feel like everything around you is shifting—and you don't know why? Relationships change. Routines unravel. Your once-solid footing suddenly feels shaky. But what if you're not falling apart… what if you're being repotted?In this deeply personal and Spirit-led episode, Sherry invites you into a powerful conversation about what it looks like when God begins to gently loosen your roots—not to break you, but to grow you. Through the lens of her own current season of transition, she shares what it means to trust the Master Gardener as He prunes, separates, and prepares us for more.This episode is for the single mom who's been pouring into everyone else's garden, wondering if God sees hers. Spoiler alert: He does.

Show Notes: In this episode, we spotlight a groundbreaking advancement in transplantation offering new hope to patients with stage 4 colorectal cancer. At Northwestern Medicine, surgeons successfully split a donor's liver to save two lives. One portion of the donor's liver went for a traditional waitlist recipient, and the other portion, for a patient with advanced colorectal cancer. This approach is part of a new trial called CLEAR (Colorectal Metastasis to Liver Extraction with Auxiliary Transplant and Delayed Resection). We're joined by Barclay Missen, the first Northwestern patient to undergo this innovative transplant and Dr. Satish Nadig, who shares how the CLEAR program is reshaping outcomes for patients. In our Mental Health Moment, we discuss tips for navigating the ups and downs of your day to maintain positive balance in your emotions, and then, honor donor hero Katherine Thiels.

AP correspondent Marcela Sanchez reports corals from the Caribbean are teaming up with Florida's reefs to fight agasint climate change.

This week on ‘The Write Question,' host Lauren Korn speaks with Daniel Tam-Claiborne, author of ‘Transplants' (Regalo Press).

This week on ‘The Write Question,' host Lauren Korn speaks with Daniel Tam-Claiborne, author of ‘Transplants' (Regalo Press).

Scripture Reflection for July 3, 2025: A Divine Heart Transplant (recorded earlier) by Priests for Life

Melissa Carter and David Manuel share their personal experiences as kidney and liver transplant recipients, discussing the emotional and physical challenges they faced. They explore the importance of organ donation, the healing power of nature, and the bonds formed through shared experiences of illness and recovery. David's journey from illness to recovery and his commitment to raising awareness about organ donation is highlighted, along with the significance of connecting with nature for emotional healing. www.chattnaturecenter.org Chapters 00:00 Transplant Journeys: Personal Stories of Resilience06:00 The Emotional Impact of Organ Transplants11:57 Connecting with Nature: Healing and Reflection18:01 The Gift of Life: Organ Donation AwarenessSee omnystudio.com/listener for privacy information.

Hosts Roz and Alberto discuss the key articles of the July issue of the American Journal of Transplantation. [03:48] Liver transplantation for hepatitis D virus/hepatitis B virus coinfection in Italy: an intention-to-treat analysis of long-term outcomes [13:42] 10 degree C static storage of porcine donation after circulatory death livers improves biliary viability and mitigates ischemia-reperfusion injury [22:20] Fewer medullary pyramids in the living kidney donor are associated with graft failure in the recipient [33:35] Microvascular inflammation in kidney allografts: New directions for patient management MOMOT (Mouse Models in Transplant) articles: Can mouse kidney transplant models inform mechanisms of injury and acceptance in clinical kidney transplantation? Best practices in islet transplantation in mice

Content managed by ContentSafe.coSupport the show

Dr. Galati is back in the studio tonight and starts with his thoughts about an article on marijuana use. He also has Dr. Caroline Simon and Yee Lee Cheah join to talk about liver transplant and robotic surgery. They also discuss the evaluation of potential donors and the importance of taking care of the liver.  

Fr. Jacob and Fr. Sean discuss Fr. Jacob's latest hobby, gardening, and the spiritual analogies he's gleaned from his successes and failures striving to be a green thumb.

This week we speak with congenital heart surgeon T. Konrad Rajab of Arkansas Children's Hospital about a recent report he co-authored on piglet experiments on partial heart transplantation. How did transplanted heart valves grow in comparison to standard homografts and how did the valvular function differ with time? Is there a minimum dose of immunosuppresion that can protect these valves and can this dose be lower than full heart transplantation immunosuppresion therapy? Is partial heart transplantation considered a potential life-long approach to valve replacement or mostly something used to allow for growth of valves during childhood? What do we know about the world's limited experience in humans of this approach? Dr. Rajab shares the answers this week in an exciting 'sci-fi' episode. The future is now.https://doi.org/10.1016/j.jacbts.2024.10.015

In this week's episode, we'll learn about using AI to assess transplant risk in myelofibrosis. In a step toward personalized medicine, researchers report on a machine learning model that identifies 25% of patients with poor outcomes. After that: preventing priapism in men with sickle cell anemia. A recent phase 2 feasibility study shows high rates of recruitment, retention, and adherence to oral therapies, coupled with a significant reduction in the risk of this difficult complication. Finally, new research indicates that hallmarks of terminal T-cell exhaustion are absent in multiple myeloma, from diagnosis through maintenance therapy. We explore these provocative and counterintuitive findings arising from profiling of blood and marrow samples.Featured Articles:Use of machine learning techniques to predict poor survival after hematopoietic cell transplantation for myelofibrosisA controlled trial for preventing priapism in sickle cell anemia: hydroxyurea plus placebo vs hydroxyurea plus tadalafilHallmarks of T-cell exhaustion and antigen experience are absent in multiple myeloma from diagnosis to maintenance therapy

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning speaks with Dr. David Kalfa, the incoming Chief of Pediatric Cardiac Surgery and Co-Director of the Heart Institute at Nicklaus Children's Hospital in Miami, about allogeneic mitral valve transplants. Chapters 00:00 Intro 01:46 Interview Preview 02:54 MV Surgery After Failed Intervention 07:46 Tears Predict Outcomes After Hemi-Arch 10:32 Pain Catastrophizing Scale 14:27 ARR w Stentless Biopros, Sex Difference 16:38 Open Implant TAV via Redo Sternotomy 19:05 Repeat Sternotomy w Completion Unifocaliz 21:07 Direct Aortic Impella 5.5 in PC Shock 25:16 Dr. Kalfa Interview, AMV Transplant 39:58 Upcoming Events 41:26 Closing They discuss methods for obtaining a mitral valve for transplantation, and topics such as immunosuppression, aortic coagulation, and the progress that has been made in this field. They also explore how to perform a living allogeneic heart valve transplant and the future of this technique.   Joel also highlights recent JANS articles on mitral valve surgery after failed transcatheter intervention for mitral regurgitation, whether distal anastomotic new entry tears predict long-term outcomes after hemiarch repair for DeBakey I aortic dissection, using a pain catastrophizing scale as a predictor for acute postoperative pain following video-assisted thoracoscopic surgery lobectomy, and sex difference in aortic root replacement with a stentless bioprosthesis.  In addition, Joel explores an open implantation of a transcatheter aortic valve via redo sternotomy, mitral valve replacement, and tricuspid valve repair in a high-risk patient, repeat sternotomy with completion unifocalization and extensive pulmonary arterial reconstruction in ToF/PA/MAPCAs, and direct aortic Impella 5.5 in post-cardiotomy shock. Before closing, Joel highlights upcoming events in CT surgery.    JANS Items Mentioned  1.) Mitral Valve Surgery After Failed Transcatheter Intervention for Mitral Regurgitation: Techniques, Challenges, and Outcomes  2.) Distal Anastomotic New Entry Tears Predict Long-Term Outcomes After Hemi-Arch Repair for DeBakey I Aortic Dissection  3.) Pain Catastrophizing Scale as a Predictor for Acute Postoperative Pain Following Video-Assisted Thoracoscopic Surgery Lobectomy  4.) Sex Difference in Aortic Root Replacement With a Stentless Bioprosthesis  CTSNET Content Mentioned  1.) Open Implantation of a Transcatheter Aortic Valve via Redo Sternotomy, Mitral Valve Replacement, and Tricuspid Valve Repair in a High-Risk-Patient  2.) Challenging Pulmonary Arterial Reconstruction: Repeat Sternotomy With Completion Unifocalization and Extensive Pulmonary Arterial Reconstruction in ToF/PA/MAPCAs   3.) Direct Aortic Impella 5.5 in Post-Cardiotomy Shock  Other Items Mentioned  1.) Allogeneic Mitral Valve Transplant: Historical Precedent, Current Considerations, and Future Implementation  2.) Cardiac Surgical Arrest—An International Conversation, Part 1  3.) Winners of the 2025 CTSNet Instructional Video Competition  4.) Career Center   5.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

On the phone-in: you share your stories of random acts of kindness with journalist and author of Every Little Thing, Janice Landry. And off the top of the show, lung transplant patients in the Maritimes need to travel to Toronto for treatment. We hear how they face a growing number of out of pocket costs.

Send us a textLeonard Goldberg stops by the show to discuss his latest release, A Scandalous Affair, from his Daughter of Sherlock Holmes mystery series. We also discuss how his research career led him to become a writer. We talk about his process and more. ****Leonard Goldberg is an internationally bestselling author of the Joanna Blalock series of medical thrillers. His novels, acclaimed by critics as well as fellow authors, have been translated into a dozen languages and sold more than a million copies worldwide. Leonard Goldberg is himself a consulting physician affiliated with the UCLA Medical Center, where he holds an appointment as Clinical Professor of Medicine. A highly sought-after expert witness in medical malpractice trials, he is board-certified in internal medicine, hematology, and rheumatology, and has published over a hundred scientific studies in peer-reviewed journals.Leonard Goldberg's writing career began with a clinical interest in blood disorders. While involved in a research project at UCLA, he encountered a most unusual blood type. The patient's red blood cells were O-Rh null, indicating they were totally deficient in A, B, and Rh factors and could be administered to virtually anyone without fear of a transfusion reaction. In essence, the patient was the proverbial "universal" blood donor. This finding spurred the idea for a story in which an individual was born without a tissue type, making that person's organs transplantable into anyone without worry of rejection. His first novel, TRANSPLANT, revolved around a young woman who is discovered to be a universal organ donor and is hounded by a wealthy, powerful man in desperate need of a new kidney. The book quickly went through multiple printings and was optioned by a major Hollywood studio.The Daughter of Sherlock mystery series, including Leonard's newest title, A SCANDALOUS AFFAIR (Pegasus Crime; Available now; ISBN-13: 9781639368358), follows Irene Adler and Sherlock's daughter years after Holmes has passed away, as she joins Dr. Watson's son in solving cases, using her quick wit and remarkable observations to carry on her father's legacy. If you haven't dipped into this clever and compelling series yet, trust the recommendation of New York Times bestselling author Tess Gerritsen, who says, "Fans of Sherlock Holmes will be thrilled to meet his fearless and brilliant daughter, Joanna."Leonard Goldberg celebrates Sherlock's enduring legacy and understands why readers and viewers continue to be captivated by it today.*****If you would like to contact the show about being a guest, please email us at Dauna@bettertopodcast.comUpcoming guests can be found: https://dmneedom.com/upcoming-guest Follow us on Social MediaInstagram: https://www.instagram.com/author_d.m.needom/Facebook: https://www.facebook.com/bettertopodcastwithdmneedomIntro and Outro music compliments of Fast Suzi©2025 Better To...Podcast with D. M. NeedomSupport the show

In the next installment of ASTCT's Titans of Transplant series, Dr. Shernan Holtan sits down with Dr. Daniel Weisdorf—renowned leader, mentor and pioneer in cellular therapy and transplantation—for a reflective and engaging conversation on the evolution of the field. From the early days of sibling-only donors and bone marrow harvests to today's innovations in GVHD prophylaxis and cord blood transplantation, Dr. Weisdorf shares personal anecdotes, pivotal clinical insights and lessons in mentorship, writing and research. Together, they explore the milestones, challenges and future directions in transplant and cellular therapy—offering a powerful perspective on what it means to make a lasting impact in patient care and scientific progress.

Nine years ago, Mark Durante received a heart transplant that saved his life—but it was just the beginning of his healing journey. When post-transplant neuropathy nearly disabled him, he turned to a friend in stem cell research. What happened next changed everything.This episode dives deep into how exosomes work, what makes 3D manufacturing a breakthrough, and why regenerative medicine isn't just for the rich and famous anymore. We compare exosomes to stem cells, explore cost and accessibility, and look at the growing global research. Whether you're a practitioner or just health-curious, this conversation might change the way you think about aging, healing, and what's possible for the human body.HIGHLIGHTS[01:10] – Mark's heart transplant story and how post-op pain led to a regenerative medicine journey[02:45] – Discovering exosomes through stem cell therapy and getting off neurological meds[05:22] – The birth of Rise Up Medical and turning healing into purpose[09:00] – Exosomes 101: what they are and why they matter[11:30] – Stem cells vs exosomes: when and why they're used[16:00] – The 3D manufacturing breakthrough and why it changes everything[22:30] – Use cases: from arthritis to anti-aging to advanced neurological support[29:00] – What regenerative treatments cost—and why smart dosing matters[34:40] – How to find a practitioner or get your doctor on board[43:00] – Global studies, real results, and what's coming next in regenerative careGUEST RESOURCESRize Up Medical: https://www.rizeupmedical.comContact Mark's Team: 469-269-0844Instagram: https://www.instagram.com/rizeupmedicalUpgrade Your WellnessBEAM Minerals: http://beamminerals.com/beautifullybrokenUse code beautifullybroken for 20% offFlowpresso: https://calendly.com/freddiekimmel/flowpresso-one-on-one-discoverySilver Biotics Wound Healing Gel: https://bit.ly/3JnxyDD30% off Use Code: BEAUTIFULLYBROKEN for DiscountStemRegen: https://www.stemregen.co/products/stemregen?_ef_transaction_id=&oid=1&affid=52Code: beautifullybrokenLightPathLED: https://lightpathled.pxf.io/c/3438432/2059835/25794code: beautifullybroken CONNECT WITH FREDDIECheck out my website and store: (http://www.beautifullybroken.world) Instagram: (https://www.instagram.com/beautifullybroken.world/) YouTube: (https://www.youtube.com/@BeautifullyBrokenWorld)

I'm joined today by two special guests to discuss an unusual and ethically complex type of organ donation – imminent death donation, or IDD. As you'll hear Thao Galvan explain in the episode, organ donation currently has three standard types: living donation, donation after brain death (a type of deceased donation in which the patient is declared brain dead, and thus legally dead), and donation after circulatory death, or DCD. In DCD, a patient who is not brain dead is removed from life support, but the heart keeps beating. If it takes the patient more than roughly 90 minutes to die, the organs may not be usable. IDD, or imminent death donation, attempts to prevent that, by retrieving non-vital organs (usually a kidney) for donation prior to the removal of life support. Thao Galvan is a transplant surgeon and professor of surgery at Baylor College of Medicine. Kathy Osterrieder is a retired financial analyst, who came to this issue after attempting, unsuccessfully, to donate the organs of her late husband, Robert Osterrieder, after making the difficult decision to remove him from life support. It is another first for the Taboo Trades podcast – the first time in over five years of recording that I've been unable to hold back the tears, as Kathy talks about what the experience was like for her family. LinksHost: Kimberly D. Krawiec, Charles O. Gregory Professor of Law, University of VirginiaGuests: Nhu Thao Nguyen Galvan, M.D., M.P.H., FACS, Associate Professor of Surgery, Baylor College of MedicineKathleen Osterrieder, Donor Family Member in Spirit, Retired Financial AnalystReading: The Difficult Ethics of Organ Donations From Living Donors, Wall St. J. (2016)Let's change the rules for organ donations — and save lives, Wash. Post (2019)OPTN, Ethical considerations of imminent death donation white paper (2016)Survey of public attitudes towards imminent death donation in the United States, Am. J. Transplant. (2020)

Andrew Widman shares his extraordinary journey of getting a heart transplant. His attitude, faith and love of family is all heart, and them some.

In this powerful episode of the We Talk Health podcast, Loren Newton shares his inspiring journey as a heart transplant recipient. From the moment he learned he needed a new heart to the challenges and triumphs of recovery, Loren offers a firsthand look at what it means to receive the gift of life. His story is a moving reminder of the importance of organ donation and the hope it brings to so many.Tune in to hear Loren's heartfelt testimonial and learn how you can make a difference by becoming an organ donor.Guest:Loren NewtonHeart Transplant RecipientHost:Kara MobleySocial Media CoordinatorResources:Donate Lifebethegifttoday.com

SLPs Meg Lico and Kaitlin Hanley from NYU Langone Health share their story of working with Aaron James, the recipient of what's being called as the first ever full-eye and partial-face transplant. They describe how they worked with James to reach his goals, such as eating solid foods with his family.Central to the story is their collaboration and the interdepartmental communication that made success possible. The SLPs provide details about approaching this unique case, as well as their victories, memorable moments, and the emotions they had along the way.At the end of the conversation, hear from James and his wife Meagan.(This conversation was originally published in February 2024.)Learn More:Swallowing Function After Pioneering Partial Face and Whole Eye Transplant: Clinical InsightsFacing the Unknown: An SLP treated a patient before and after his facial transplant surgery.Changes in Articulatory Control Pre– and Post–Facial Transplant: A Case ReportThe Effects of Lip-Closure Exercise on Lip Strength and Function Following Full Facial Transplantation: A Case ReportTranscript

This is the morning All Local update for Wednesday, June 18, 2025.

The Liver Transplant Program at Michigan Medicine has seen unprecedented success in recent years. Indeed, the team is leading the way when it comes to who is receiving transplants and ensuring successful outcomes for patients and donors. You can learn more about these incredible advancements, about transplantation in general and the unique aspects of the living donor program on the latest episode of The Wrap. Check it out today! Hosted on Acast. See acast.com/privacy for more information.

In a story of overcoming obstacles, public speaker and author of "Triumph: Life on the Other Side of Trials, Transplants, Transition and Transformation" joins the show. Works suffers from PKD and he shares what inspired the creation of the book.

Joseph Yao, M.D., explains how Mayo Clinic Laboratories' new quantitative assay (Mayo ID: ADVQU) goes beyond qualitative testing to evaluate transplant patients for adenovirus infection. Adenovirus can cause life-threatening disease in immunocompromised transplant patients, especially children.(01:14)Could you give us a brief overview of this assay? (02:06)Can you explain the differences of the qualitative and quantitative methods and why we made the change to a quantitative adenovirus method? (04:00)When is this test typically ordered for transplant patients? Is it used throughout their treatment? (06:56)Could an immunocompromised person be unknowingly infected? (07:31)Is our quantitative method approved for pediatric patients? (08:00)How are the test results used to treat patients?(10:36)What other infections might providers consider alongside adeovirus?

4 months post transplant

...for this one, Paul Viafranco, we connected at the NAMI walk. Paul told me a bit coming here from San Antonio, but also, he's part of the Kidney Foundation of NWO. THAT is an organ we've never discussed on the show, but the health of it, and yours, tracks back to SO many things we've discussed in the past about improving the health of our community. Paul is also the first ever person to bring up Good Reads on the show!See omnystudio.com/listener for privacy information.

Dr. Sabine Hazen is a Gastroenterologist, Researcher, & CEO of Progena Biome. In this episode, she explains how fecal microbiota transplants (FMT) have the potential to treat Alzheimer's, Autism, Crohn's, Anxiety, Depression & Alopecia. She explains how it works, why mapping the microbiome is like mapping the human genome & interesting cases of personality changes post transplant. If you like this episode, you'll also like episode 188: BIOHACKING FOR DUMMIES: SUNSHINE, SLEEP & SHIVERS Guest: https://sabinehazanmd.com/ | https://x.com/SabinehazanMD | https://www.facebook.com/DoctorSabineHazan | https://www.instagram.com/dr.sabinehazan/ | https://www.linkedin.com/in/sabine-hazan-steinberg-md-5343b241/ | https://biomeboosters.com/ | https://progenabiome.com/ Host:  https://www.meredithforreal.com/  | https://www.instagram.com/meredithforreal/  | meredith@meredithforreal.com | https://www.youtube.com/meredithforreal  | https://www.facebook.com/meredithforrealthecuriousintrovert Sponsors: https://www.jordanharbinger.com/starterpacks/ | https://uwf.edu/university-advancement/departments/historic-trust/ 

What's got you feeling good going into the weekend? Learn more about your ad choices. Visit megaphone.fm/adchoices

I get DMs all the time about things people love or hate about L.A. and one of the things people 'hate' the most are the transplants. Another thing people 'hate' are the natives. So who is right? Why do natives hate transplants and transplants hate natives? I dive into this dichotomy which is actually L.A.'s Civil War.

Bill rambles about Little Italy, redhead confidence, and a hair transplant at twenty-four. Ava: Download the Ava app today, and when you join using my promo code BURRFREE, you’ll get your first month FREE! This offer is only for MY listeners. OpenPhone: Go to www.OpenPhone.com/BURR and get 20% off your first six months.